A useful modification of cDNA that enhances purification of recombinant protein

With the availability of new and improved DNA vectors for producing large amounts of proteins by recombinant DNA technology, there is a growing need for efficient recovery of the desired protein, often from liters of culture medium. In this report, we describe a relatively simple modification of rec...

Description complète

Détails bibliographiques
Publié dans:BioTechniques. - 1991. - 12(1992), 5 vom: 01. Mai, Seite 645-50
Auteur principal: Drake, L (Auteur)
Autres auteurs: Barnett, T
Format: Article
Langue:English
Publié: 1992
Accès à la collection:BioTechniques
Sujets:Journal Article Codon DNA, Recombinant Imino Acids Recombinant Proteins zinc(II)-iminodiacetate agarose Histidine 4QD397987E Sepharose 9012-36-6
LEADER 01000caa a22002652c 4500
001 NLM014966166
003 DE-627
005 20250124171704.0
007 tu
008 231221s1992 xx ||||| 00| ||eng c
028 5 2 |a pubmed25n0050.xml 
035 |a (DE-627)NLM014966166 
035 |a (NLM)1515129 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Drake, L  |e verfasserin  |4 aut 
245 1 2 |a A useful modification of cDNA that enhances purification of recombinant protein 
264 1 |c 1992 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 06.10.1992 
500 |a Date Revised 21.11.2013 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a With the availability of new and improved DNA vectors for producing large amounts of proteins by recombinant DNA technology, there is a growing need for efficient recovery of the desired protein, often from liters of culture medium. In this report, we describe a relatively simple modification of recombinant cDNA, that, in combination with immobilized metal affinity chromatography, is a rapid, inexpensive and highly effective method for enriching or purifying a desired protein 
650 4 |a Journal Article 
650 7 |a Codon  |2 NLM 
650 7 |a DNA, Recombinant  |2 NLM 
650 7 |a Imino Acids  |2 NLM 
650 7 |a Recombinant Proteins  |2 NLM 
650 7 |a zinc(II)-iminodiacetate agarose  |2 NLM 
650 7 |a Histidine  |2 NLM 
650 7 |a 4QD397987E  |2 NLM 
650 7 |a Sepharose  |2 NLM 
650 7 |a 9012-36-6  |2 NLM 
700 1 |a Barnett, T  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t BioTechniques  |d 1991  |g 12(1992), 5 vom: 01. Mai, Seite 645-50  |w (DE-627)NLM012627046  |x 1940-9818  |7 nnas 
773 1 8 |g volume:12  |g year:1992  |g number:5  |g day:01  |g month:05  |g pages:645-50 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_21 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_60 
912 |a GBV_ILN_62 
912 |a GBV_ILN_65 
912 |a GBV_ILN_70 
912 |a GBV_ILN_99 
912 |a GBV_ILN_121 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_350 
912 |a GBV_ILN_618 
912 |a GBV_ILN_640 
912 |a GBV_ILN_754 
912 |a GBV_ILN_2001 
912 |a GBV_ILN_2002 
912 |a GBV_ILN_2003 
912 |a GBV_ILN_2005 
912 |a GBV_ILN_2006 
912 |a GBV_ILN_2007 
912 |a GBV_ILN_2008 
912 |a GBV_ILN_2009 
912 |a GBV_ILN_2010 
912 |a GBV_ILN_2012 
912 |a GBV_ILN_2015 
912 |a GBV_ILN_2018 
912 |a GBV_ILN_2023 
912 |a GBV_ILN_2035 
912 |a GBV_ILN_2040 
912 |a GBV_ILN_2060 
912 |a GBV_ILN_2099 
912 |a GBV_ILN_2105 
912 |a GBV_ILN_2121 
912 |a GBV_ILN_2470 
951 |a AR 
952 |d 12  |j 1992  |e 5  |b 01  |c 05  |h 645-50